METHOD FOR PREDICTING THE RESPONSE TO CHEMOTHERAPY IN A PATIENT SUFFERING FROM OR AT RISK OF DEVELOPING RECURRENT BREAST CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15275150

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for predicting a response to and/or benefit of chemotherapy, including neoadjuvant chemotherapy, in a patient suffering from or at risk of developing recurrent neoplastic disease, in particular breast cancer, said method comprising the steps of:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MYRIAD INTERNATIONAL GMBHNATTERMANNALLEE 1 COLOGNE 50829

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brase, Jan Christoph Cologne, DE 7 6
Gehrmann, Mathias Leverkusen, DE 29 184
Kronenwett, Ralf Cologne, DE 17 24
Petry, Christoph Neuss, DE 22 167
Weber, Karsten Leverkusen, DE 27 104

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation